Evidence method
Level · gp.fundamentals.debt_to_revenue
270.10% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
APYX · Jun 30, 2026
Apyx Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-26-026346General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.48% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-25.14% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
22.08% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
77.41% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
63.89% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-13.01% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7.74% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20247/9 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20257/9 normalizedLevel 3Jun 30, 20257/9 normalizedLevel 3Sep 30, 20258/9 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 300.24%
- Current
- 270.10%
- Delta
- -30.15%
- Previous
- 0.48%
- Current
- 0.48%
- Delta
- -0.01%
- Previous
- -4.58%
- Current
- -25.14%
- Delta
- -20.56%
- Previous
- 32.45%
- Current
- 22.08%
- Delta
- -10.37%
- Previous
- 76.35%
- Current
- 77.41%
- Delta
- 1.06%
- Previous
- 63.45%
- Current
- 63.89%
- Delta
- 0.44%
- Previous
- -7.29%
- Current
- -13.01%
- Delta
- -5.71%
- Previous
- 6.12%
- Current
- 5.71%
- Delta
- -0.41%
- Previous
- 2.50%
- Current
- 7.74%
- Delta
- 5.24%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Surgical & Medical Instruments & Apparatus peers →Has State · Apyx Medical Corp →Transitioned To · APYX Fundamental State →Transitioned To · APYX BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · APYX CAPEX_INTENSITY_DECREASED →Transitioned To · APYX CASH_GENERATION_DECREASED →Transitioned To · APYX GROWTH_DECREASED →Transitioned To · APYX INVENTORY_PRESSURE_INCREASED →Transitioned To · APYX MARGIN_INCREASED →Transitioned To · APYX PROFITABILITY_DECREASED →Transitioned To · APYX R_AND_D_INTENSITY_DECREASED →Transitioned To · APYX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.